Anticancer pan-ErbB inhibitors reduce inflammation and tissue injury and exert broad-spectrum antiviral effects

Author:

Saul Sirle,Karim MarwahORCID,Ghita LucaORCID,Huang Pei-Tzu,Chiu WinstonORCID,Durán VerónicaORCID,Lo Chieh-WenORCID,Kumar Sathish,Bhalla Nishank,Leyssen PieterORCID,Alem FarhangORCID,Boghdeh Niloufar A.ORCID,Tran Do H.N.,Cohen Courtney A.,Brown Jacquelyn A.,Huie Kathleen E.ORCID,Tindle Courtney,Sibai Mamdouh,Ye ChengjinORCID,Khalil Ahmed MagdyORCID,Chiem Kevin,Martinez-Sobrido LuisORCID,Dye John M.ORCID,Pinsky Benjamin A.ORCID,Ghosh Pradipta,Das Soumita,Solow-Cordero David E.ORCID,Jin JingORCID,Wikswo John P.ORCID,Jochmans DirkORCID,Neyts JohanORCID,De Jonghe StevenORCID,Narayanan Aarthi,Einav ShiritORCID

Funder

Department of Defense (DoD)/Congressionally Directed Medical Research Programs

Defense Threat Reduction Agency (DTRA)/Fundamental Research to Counter Weapons of Mass Destruction

National Institutes for Health

Publisher

American Society for Clinical Investigation

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3